|
Obesity has been gradually reaching out to an alarming state all
over the world today merely because of the changed lifestyle and
food habits. Many pharmaceutical companies in the world have
introduced various anti-obesity drugs that are proving to be
effective to great extent in most of the cases except some typical
cases. Reductil developed and produced by Abbott Laboratories has
been formulated by using Sibutramine Hydrochloride Monohydrate as
the active pharmaceutical ingredient-API for obesity drive only.
When Sibutramine-Reductil is taken, it acts by enhancing
noradrenalin and serotonin neurotransmitter levels in the nerve
cells of the brain. The increased levels of serotonin results in
lowering appetite and making the person feel sense of fullness. Now
since the appetite is reduced, the food intake by the obese person
would naturally be decreased subsequently which in turn lead to
reduced formation of fats in the body. Thus unlike other diet pills,
Reductil–Sibutramine Hydrochloride Monohydrate helps fighting
obesity right from its root in the brain and proves its great
efficacy.
The hunger signals are completely blocked by this medication and
giving the sense of fullness to the person taking it makes him eat
less than required and in due course the less amount of fat intake
results in weight loss or helping shred off obesity gradually. The
treatment of Reductil–Sibutramine Hydrochloride Monohydrate is
exclusively prescribed by the physician based on the medical
condition of the individual person. At times, the treatment is
accompanied by some recommended exercise plans also. The perfect
combination in such treatments proves to be highly effective in most
of the cases.
|